简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-06-03 10:54 Boehringer Ingelheim launches ambitious ELUXA trial programme to broadly investigate promising lung cancer compound olmutinib
2016-06-02 17:08 Arcadia Biosciences and DuPont Pioneer Achieve Milestone in the Development of High-Value Specialty Oil
2016-06-02 16:57 SuperECG: BeatScanner App for Your Rhythms
2016-06-02 14:03 Worldwide Innovative Networking (WIN) in Personalized Cancer Medicine is Very Proud to Announce That Institut Curie, France Has Joined Its Consortium
2016-06-02 10:02 ANGUS Introduces New Excipient for Enhanced Purification of Large-Scale Drug Manufacturing
2016-06-01 15:40 Quintiles Introduces Precision Enrollment to Enhance Patient Recruitment in Oncology Trials
2016-05-31 16:09 Boehringer Ingelheim and Inventiva collaborate to develop potential new treatments for idiopathic pulmonary fibrosis
2016-05-31 15:00 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as Consolidation Treatment in Post-Transplant Hodgkin Lymphoma
2016-05-31 13:53 Takeda Provides Update on EU Marketing Authorization Application for NINLARO® (ixazomib) in Relapsed/Refractory Multiple Myeloma
2016-05-30 15:51 Korean Plastic Surgery Ensuring Safe and Sleek V-Line Facial Contouring Surgery
2016-05-30 14:30 Samsung Bioepis Becomes First to Obtain European Commission Approval for Second Anti-TNF-α Biosimilar with Flixabi®
2016-05-27 15:02 Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress
2016-05-27 10:11 3 out of 4 people with symptomatic asthma report reduced productivity at work
2016-05-26 17:03 Herbalife Sponsors Four National Olympic Committees at Rio 2016 Olympics and Paralympic Games
2016-05-26 15:34 Sumitomo Heavy Industries Announces Samsung Medical Center Starts Proton Therapy
2016-05-26 14:14 "Rising Expectations" before the Release of 3 Products in Accoje Whitening Capsule Line
2016-05-25 14:22 Ferring Pharmaceuticals: World Bedwetting Day 2016 - New Evidence Confirms the Impact of Bedwetting on Children’s Daytime Functioning
2016-05-25 10:30 IL-23 inhibitor risankizumab induces remission in Phase II study in patients with moderate-to-severe Crohn’s disease
2016-05-25 09:40 RayVio Launches Industry-Leading Ultraviolet LEDs to Enable Clean Water and Environments
2016-05-24 10:59 Samsung Bioepis' Biologics License Application for SB2 Infliximab Biosimilar Accepted by U.S. Food and Drug Administration

Business Wire Weibo

Press Releases

Latest Releases